» Articles » PMID: 38402393

Association of the Triglyceride-glucose Index with All-cause and Cardiovascular Mortality in Patients with Cardiometabolic Syndrome: a National Cohort Study

Abstract

Objective: This study aimed to evaluate the association of triglyceride-glucose (TyG) index with all-cause and cardiovascular mortality risk among patients with cardiometabolic syndrome (CMS).

Methods: We performed a cohort study of 5754 individuals with CMS from the 2001-2018 National Health and Nutrition Examination Survey. The TyG index was calculated as Ln [fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2]. Multivariate Cox proportional hazards regression models assessed the associations between TyG index and mortality . Non-linear correlations and threshold effects were explored using restricted cubic splines and a two-piecewise Cox proportional hazards model.

Results: Over a median follow-up of 107 months, 1201 all-cause deaths occurred, including 398 cardiovascular disease-related deaths. The multivariate Cox proportional hazards regression model showed a positive association between the TyG index and all-cause and cardiovascular mortality. Each one-unit increase in the TyG index was associated with a 16% risk increase in all-cause mortality (HR: 1.16, 95% CI 1.03, 1.31, P = 0.017) and a 39% risk increase in cardiovascular mortality (HR: 1.39, 95% CI 1.14, 1.71, P = 0.001) after adjusting for confounders. The restricted cubic splines revealed a U-shaped association between the TyG index and all-cause (P for nonlinear < 0.001) and cardiovascular mortality (P for nonlinear = 0.044), identifying threshold values (all-cause mortality: 9.104; cardiovascular mortality: 8.758). A TyG index below these thresholds displayed a negative association with all-cause mortality (HR: 0.58, 95% CI 0.38, 0.90, P = 0.015) but not with cardiovascular mortality (HR: 0.39, 95% CI 0.12, 1.27, P = 0.119). Conversely, a TyG index exceeding these thresholds was positively associated with all-cause and cardiovascular mortality (HR: 1.35, 95% CI 1.17, 1.55, P < 0.001; HR: 1.54, 95% CI 1.25, 1.90, P < 0.001, respectively). Notably, a higher TyG index (≥ threshold values) was significantly associated with increased mortality only among individuals aged under 55 compared to those with a lower TyG index (< threshold values).

Conclusions: The TyG index demonstrated a U-shaped correlation with all-cause and cardiovascular mortality in individuals with CMS. The thresholds of 9.104 and 8.758 for all-cause and cardiovascular mortality, respectively, may be used as intervention targets to reduce the risk of premature death and cardiovascular disease.

Citing Articles

Inflammatory markers mediate the association between weight-adjusted waist circumference and mortality in patients with cardiometabolic syndrome.

Wang H, Cai W, Zeng H, Xu Z, Luo X, Wu J Sci Rep. 2025; 15(1):8505.

PMID: 40075096 PMC: 11903782. DOI: 10.1038/s41598-025-92733-y.


Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0-3: a cohort study.

Zhang P, Mo D, Zeng W, Dai H Cardiovasc Diabetol. 2025; 24(1):92.

PMID: 40022225 PMC: 11871745. DOI: 10.1186/s12933-025-02642-7.


Association between triglyceride glucose index and biological aging in U.S. adults: National Health and Nutrition Examination Survey.

Pan L, Jin L Cardiovasc Diabetol. 2025; 24(1):100.

PMID: 40022176 PMC: 11871761. DOI: 10.1186/s12933-025-02631-w.


The association between novel metabolic parameters and all-cause/cardiovascular mortality in patients with metabolic syndrome is modified by age.

Liu J, Fu Y, Liang P, Song Z, Li Y, Wu H Cardiovasc Diabetol. 2025; 24(1):96.

PMID: 40022121 PMC: 11871838. DOI: 10.1186/s12933-025-02587-x.


Association Between Triglyceride-Glucose Related Index and Endometriosis Varies According to Educational Level.

Lin C, Wu Q, Luo Z, Du J, Hong S, Chae H Nutrients. 2025; 17(4).

PMID: 40004998 PMC: 11858264. DOI: 10.3390/nu17040670.


References
1.
Gluvic Z, Zaric B, Resanovic I, Obradovic M, Mitrovic A, Radak D . Link between Metabolic Syndrome and Insulin Resistance. Curr Vasc Pharmacol. 2016; 15(1):30-39. DOI: 10.2174/1570161114666161007164510. View

2.
Lee J, Han K, Huh J . The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study. Cardiovasc Diabetol. 2020; 19(1):44. PMC: 7110776. DOI: 10.1186/s12933-020-01021-8. View

3.
Jeppesen J, Hansen T, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S . Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol. 2007; 49(21):2112-9. DOI: 10.1016/j.jacc.2007.01.088. View

4.
Tune J, Goodwill A, Sassoon D, Mather K . Cardiovascular consequences of metabolic syndrome. Transl Res. 2017; 183:57-70. PMC: 5393930. DOI: 10.1016/j.trsl.2017.01.001. View

5.
Hill M, Yang Y, Zhang L, Sun Z, Jia G, Parrish A . Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021; 119:154766. DOI: 10.1016/j.metabol.2021.154766. View